Current perspectives of electrical remodeling and its therapeutic implications

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 9, Issue 2, 2004, Pages 129-144

  Wasson, Sanjeev ^a   Reddy, H K ^a   Dohrmann, Mary L ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Atrial fibrillation; Electrical remodeling; Hypertrophy; Ischemia; Structural remodeling

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCINEURIN; CALCIUM ION; CARIPORIDE; ENDOTHELIN A RECEPTOR ANTAGONIST; INWARDLY RECTIFYING POTASSIUM CHANNEL; ION CHANNEL; POTASSIUM CHANNEL; POTASSIUM ION; SODIUM CALCIUM EXCHANGE PROTEIN;

CALCIUM CURRENT; CARDIOMYOPATHY; ELECTRICAL REMODELING; GAP JUNCTION; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; OUTWARDLY RECTIFYING POTASSIUM CHANNEL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

ACTION POTENTIALS; ARRHYTHMIA; CALCIUM CHANNELS; CARDIOMEGALY; GAP JUNCTIONS; HEART; HEART DISEASES; HUMANS; MYOCARDIAL ISCHEMIA; POTASSIUM CHANNELS; SODIUM-CALCIUM EXCHANGER;

EID: 4043131868     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840400900208     Document Type: Review

References (131)

1. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. New Engl J Med 314:1547-1552, 1986
2. Sun H, Gaspo R, Leblanc N, et al. The cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia. Circulation 98:719-727, 1998
3. Harrison TR, Pilcher C, Ewing G. Studies in congestive heart failure, IV: Potassium content of skeletal and cardiac muscle. J Clin Invest 8:325-335, 1930
4. Trautwein W, Kassebaum DG, Nelsol RM, et al. Electrophysiological study of human heart muscle. Circ Res 10:306-312, 1962
5. Gelband H, Bassett AL. Depressed transmembrane potentials during experimentally induced ventricular failure in cats. Circ Res 32:625-634, 1973
6. Ten Eick RE, Bassett AL, Robertson LL. Possible electrophysiological basis for decreased contractility associated with myocardial hypertrophy in the cat: A voltage clamp approach. In: Alpert NR, ed. Perspectives in Cardiovascular Research: Myocardial Hypertrophy and Failure. New York, NY: Raven Press; pp. 245-259, 1983
7. Kaab S, Dixon J, Dc J, et al. Molecular basis of transient outward potassium current down-regulation in human heart failure: A decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 98:1383-1393, 1998
8. Choy A-M, Kuperschmidt S, Lang CC, Pierson RN, Roden DM. Regional expression of HERG and KvLQT1 in heart failure. Circulation 94:1-164, 1996
9. Koumi SI, Martin RL, Sato R. Alterations in ATP in failing human hearts. Am J Physiol 272:H1665, 1997
10. Ouadid H, Albat B, Nargeot J. Calcium currents in diseased human cardiac cells. J Cardiovasc Pharmacol 25:282-291, 1995
11. 2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest 90:927-935, 1992
12. Kleiman RB, Houser SR. Calcium currents in normal and hypertrophied isolated feline ventricular myocytes. Am J Physiol 255:H1434-H1442, 1988
13. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 73:777-782, 1993
14. 2+ ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. J Mol Med 74:321-332, 1996
15. 2+-ATPase in failing and nonfailing human hearts. Cardiovasc Res 31:625-632, 1996
16. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation 90:653-657, 1994
17. 2+ exchanger peak near birth in developing rabbit and rat hearts. Circ Res 74:354-359, 1994
18. 2+ exchanger gene leads to cardiomyocyte apoptosis and defects in heartbeat. J Biol Chem 275:991-998, 2000
19. 2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 99(5):641-648, 1999
20. Bers DM, Pogwizd SM, Schlotthauer K. Upregulated Na/Ca exchange is involved in both contractile dysfunction and arrhythmogenesis in heart failure. Basic Res Cardiol 97:136-142, 2002
21. 2+exchanger in failing human myocardium. Circulation 94:992-1002, 1996
22. 2+ exchanger remodeling in pressure overload cardiac hypertrophy. J Biol Chem 276(21):1706-1711, 2001
23. Molkentin JD, Lu JR, Antos CL, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228, 1998
24. Hoppe UC, Jansen E, Sudkamp M, et al. Hyperpolorization-activated inward current in ventricular myocytes from normal and failing hearts. Circulation 97:55-65, 1998
25. + pump in failing heart muscle. Am J Physiol 240:H168-H176, 1981
26. Matsumoto Y, Aihara H, Yamauchi-Kohno R, et al. Long-term endothelin a receptor blockade inhibits electrical remodeling in cardiomyopathic hamsters. Circulation 106(5):613-619, 2002
27. + current by neurotransmitters and magnesium. Cardiovasc Drugs Ther 7(3):547-554, 1993
28. 1-Adrenoceptors in myocardium: Functional aspects and transmembrane signaling mechanisms. Physiol Rev 73:469-487, 1993
29. Pye MP, Cobbe SM. Arrhythmogenesis in experimental models of heart failure: The role of increased load. Cardiovasc Res 32:248-257, 1996
30. Darbar D, Cherry CJ, Kerins DM. QT dispersion is reduced after valve replacement in patients with aortic stenosis. Heart 82:15-18, 1999
31. Mayet J, Shahi M, McGrath K, Poulter NR, Sever PS, Foale RA, et al. Left ventricular hypertrophy and QT dispersion in hypertension. Hypertension 28:791-796, 1996
32. Reddy HK, Wasson S, Koshy SK, et al. Structural correlates of electrical remodeling in ventricular hypertrophy. Cardiovasc Res 58:495-497, 2003
33. Gonzalez-Juanatey JR, Garcia-Acuna JM, Pose A, et al. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril. American Journal of Cardiology 81:170-174, 1998
34. Hill JA, Karimi M, Kutschke W, et al. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation 101(24):2863-2869, 2000
35. Lim HW, De Windt LJ, Mante J, et al. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition. J Mol Cell Cardiol 32:697-709, 2000
36. Wang Z, Kutschke MS, Richardson KE, Karimi M, Hill JA. Electrical remodeling in pressure overload cardiac hypertrophy. Role of calcineurin. Circulation 104:1657-1663, 2001
37. Chien KR. Meeting Koch's postulates for calcium signaling in cardiac hypertrophy. J Clin Invest 105:1339-1342, 2000
38. Koshy SKG, Reddy HK, Shukla HH. Collagen cross linking: New dimension to cardiac remodeling. Cardiovasc Res 57:594-598, 2003
39. 2+ exchange activity in hypertrophied canine ventricular myocytes: Potential link between contractile adaptation and arrhythmogenesis. Circulation 102:2137-2144, 2000
40. Wang Z, Kutschke W, Richardson KE, et al. Electrical remodeling in pressure-overload cardiac hypertrophy: Role of calcineurin. Circulation 104:1657-1663, 2001
41. Boateng SY, Naqvi RU, Koban MU, et al. Low-dose ramipril treatment improves relaxation and calcium cycling after established cardiac hypertrophy. Am J Physiol 280:H1029-H1038, 2001
42. Marban E. Molecular approaches to arrhythmogenesis. In: Chien K, editor, Molecular basis of heart disease, W.B. Saunders, New York, 1998
43. Vermeulen JT, McGuire MA, Opthof T, et al. Triggered activity and automaticity in ventricular trabecular of failing human and rabbit hearts. Cardiovasc Res 28:1547-1554, 1994
44. Janse MJ, Wit AL. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 69:1049-1169, 1989
45. Tomaselli GF, Beuckelmann DJ, Calkins HG, et al. Sudden cardiac death in heart failure. The role of abnormal repolarization. Circulation 90:2534-2539, 1994
46. Berger RD, Kasper EK, Baughman KL, et al. Beat-to-beat QT interval variability: Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 96:1557-1565, 1997
47. Drouin E, Charpentier F, Gauthier C, et al. Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: Evidence for presence of M cells. J Am Coll Cardiol 26:185-192, 1995
48. Spach MS, Boineau JP. Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: A major mechanism of structural heart disease arrhythmias. Pacing Clin Electrophysiol 20:397-413, 1997
49. Peters NS. New insights into myocardial arrhythmogenesis: Distribution of gap-junctional coupling in normal, ischemic and hypertrophied human hearts. Clin Sci (Colch) 90:447-452, 1996
50. Roden DM, Kupershmidt S. From gene to channels: Normal mechanisms. Cardiovasc Res 42:318-326, 1999
51. vlptl is developmentally regulated. Hum Molec Gen 7:483-487, 1998
52. vl.1 mRNA. Proc Natl Acad Sci 95:7693-7698, 1998
53. Thomas SA, Schuessler RB, Berul CI, et al. Disparate effects of deficient expression of connexin43 on atrial and ventricular conduction: Evidence for chamber-specific molecular determinants of conduction, Circulation 97:686-691, 1998
54. Peters NS, Coromilas J, Severs NJ, et al. Disturbed connexin 43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 95:988-996, 1997
55. Kaprielian RR, Gunning M, Dupont E, et al. Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation 97:651-660, 1998
56. Darrow BJ, Fast VG, Kleber AG, et al. Functional and structural assessment of intercellular communication: Increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes. Circ Res 79:174-183, 1996
57. Bastide B, Neyses L, Ganten D, et al. Gap junction protein connexin40 is preferentially expressed in vascular endothelium and conductive bundles of rat myocardium and is increased under hypertensive conditions. Circ Res 73:1138-1149, 1993
58. Cooklin M, Wallis WRJ, Sheridan DJ, et al. Changes in cell-to-cell electrical coupling associated with left ventricular hypertrophy. Circ Res 80:765-771, 1997
59. DeBakker MJT, van Capelle FJL, Janse MJ, et al. Slow conduction in the infarcted human heart. "Zigzag" course of activation. Circulation 88:915-926, 1993
60. Spach MS, Dolber PC. Relating extra cellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Circ Res 58:356-371, 1986
61. Hasenfuss G, Meyer M, Schillinger W, et al. Calcium handling proteins in the failing human heart. Basic Res Cardiol 92 (suppl 1):87-93, 1997
62. Zipes DP. The seventh annual Gordon K. Moe Lecture. Atrial fibrillation: From cell to bedside. J Cardiovasc Electrophysiol 8:927-938, 1997
63. Bennett MA, Pentecost BL. The pattern of onset and spontaneous cessation of atrial fibrillation in man. Circulation 96:981-988, 1970
64. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659-666, 1998
65. Allessie MA, Bonke FI, Schopman FJ. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: A new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res 41:9-18, 1977
66. Ausma J, Coumans WA, Duimel H, et al. Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc Res 47:788-796, 2000
67. White CW, Kerber RE, Weiss HR, et al. The effects of atrial fibrillation on atrial pressure-volume and flow relationships. Circ Res 51:205-215, 1982
68. Bosch RF, Zeng X, Grammer JB, et al. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 44:121-131, 1999
69. Brundel BJJM, Van Gelder IC, Henning RH, et al. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 103:684-690, 2001
70. Goette AG, Honeycutt C, Langberg JJ. Electrical remodeling in AF. Time course and mechanisms. Circulation 94:2968-2974, 1996
71. Tieleman RG, De Langen CDJ, Van Gelder IC, et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 95:1945-53, 1997
72. Friedman HS, Rodney E, Sinha B, et al. Verapamil prolongs atrial fibrillation by evoking an intense sympathetic neurohumoral effect. J Invest Med 47:293-303, 1999
73. Fareh S, Benardeau A, Nattel S. Comparative study of the efficacy of T- and L-type calcium channel blockers against atrial remodeling due to sustained atrial tachycardia. Circulation 100(suppl I):I11 [abstract], 1999
74. Hobbs WJC, Todd DM, Fynn SP, et al. Verapamil accentuates rather than inhibits the self-perpetuating process in atrial fibrillation. Heart 83 (suppl 1):8, 2000
75. Fareh S, Benardeau A, Thibault B, et al. The T-type calcium channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. Circulation 100:2191-2197, 1999
76. Carnes CA, Chung MK, Nakayama T, et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 89:E32-E38, 2001
77. Korantzopoulos P, Kolettis T, Siogas K, et al. Atrial fibrillation and electrical remodeling: The potential role of inflammation and oxidative stress. Med Sci Monit 9(9):RA225-259, 2003
78. f channel mRNA in human atrial tissue: Correlation with left atrial filling pressure and atrial fibrillation. J Cardiovasc Electrophysiol 10:947-953, 1999
79. Schotten U, Greiser M, Benke D, et al. Atrial fibrillation-induced atrial contractile dysfunction: A tachycardiomyopathy of a different sort. Cardiovasc Res 53:192-201, 2002
80. 2+ exchange. Molecular and pharmacological aspects. Circ Res 88:864-876, 2001
81. Polontchouk L, Haefliger JA, Ebelt B, et al. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 38:883-891, 2001
82. Brundel BJ, Ausma J, van Gelder IC, et al. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc Res 380-389, 2002
83. Goette A, Arndt M, Rocken C, et al. Calpains and cytokines in fibrillating human atria. Am J Physiol Heart Circ Physiol 283:H264-H272, 2002
84. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 80:772-781, 1997
85. Lai LP, Su MJ, Lin JL, et al. Changes in the mRNA levels of delayed rectifier potassium channels in human atrial fibrillation. Cardiology 92:248-255, 1999
86. K.ACh and muscarinic receptor-mediated shortening of action potentials. Circulation 104:2551-2557, 2001
87. Dobrev D, Wettwer E, Kortner A, et al. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res 54:397-404, 2002
88. Miake J, Marban E, Nuss HB. Gene therapy: Biological pacemaker created by gene transfer. Nature (London) 419:132-133, 2002
89. + current in human atrial fibrillation. Their possible role in postoperative atrial fibrillation. J Mol Cell Cardiol 32:1885-1896, 2000
90. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96:1180-1184, 1997
91. Van der Velden HM, van Kempen MJ, Wijffels MC, et al. Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol 9:596-607, 1998
92. Ausma J, Dispersyn GD, Duimel H, et al. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol 32:355-364, 2000
93. Goette A, Staack T, Rocken C, et al. Increased expression of extracellular signal- regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 35:1669-1677, 2000
94. Goette A, Arndt M, Rocken C, et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 101:2678-2681, 2000
95. Shi Y, Li D, Tardif JC, et al. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res 54:456-461, 2002
96. Ausma J, Duytschaever M, Wijffels M, et al. Loss of efficacy of cardioversion by class Ic drugs after long term atrial fibrillation in the goat. Eur Heart J 21:543, 2001 [Abstract]
97. Freedberg AS, Papp JG, Williams EM. The effect of altered thyroid state on atrial intracellular potentials. J Physiol (Lond) 207:357-369, 1970
98. 2+ channels in patients with latent hyperthyroidism. Am J Physiol 278:H723-H730, 2000
99. Li D, Fareh S, Leung TK, et al. Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort. Circulation 100:87-95, 1999
100. Sanders P, Morton JB, Davidson NC, et al. Electrical remodeling of the atria in congestive heart failure: Electrophysiological and electroanatomic mapping in humans. Circulation 108(12):1461-1468, 2003
101. Li D, Shinagawa K, Pang L, et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 104:2608-2614, 2001
102. 2+ currents and human atrial fibrillation. Circ Res 85:426-428, 1999
103. Liu L, Nattel S. Differing sympathetic and vagal effects on atrial fibrillation in dogs: Role of refractoriness heterogeneity. Am J Physiol 273:H805-H816, 1997
104. Yamada M, Inanobe A, Kurachi Y. G protein regulation of potassium ion channels. Pharmacol Rev 50:723-757, 1998
105. Ramirez RJ, Nattle S, Courtemanche M. Mathematical analysis of canine atrial action potentials: Rate, regional factors and electrical remodeling. Am J Physiol (Heart Circ Physiol) 279:H1767-H1782, 2000
106. Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100:1879-1886, 1999
107. Ursell PC, Gardner PI, Albala A, et al. Structural and electrophysiological changes in the epicardial border zone of canine myocardial infarcts during infarct healing. Circ Res 56:436-451, 1985
108. Wit AL, Janse MJ. The ventricular arrhythmias of ischemia and infarction. Electrophysiological Mechanisms, Futura: Mount Kisco, NY, 1993.
109. Wong SS, Bassetrt AL, Cameron JS, et al. Dissimilarities in the electrophysiological abnormalities of lateral border and central infarct zone cells after healing of myocardial infarction in cats. Circ Res 51:486-493, 1982
110. Aggarwal R, Boyden PA. Diminished calcium and barium currents in myocytes surviving in the epicardial border zone of the 5-day infarcted canine heart. Circ Res 77:1180-1191, 1995
111. Gaide MS, Myerburg RJ, Kozlovskis PL, et al. Elevated sympathetic response of epicardium proximal to healed myocardial infarction. Am J Physiol 245:H646-H652, 1983
112. Kimura S, Bassett AL, Gaide MS, et al. Regional changes in intracellular potassium and sodium activity after healing of experimental myocardial infarction in cats. Circ Res 58:202-208, 1986
113. 2+ exchange in the infarcted heart. Implications for excitation contraction coupling. Circ Res 81:1083-1093, 1997
114. Jeck C, Pinto JMB, Boyden PA. Transient outward currents in subendocardial Purkinje myocytes surviving in the 24 and 48 h infarcted heart. Circulation 92:465-473, 1995
115. Qin D, Zhang Z-H, Caref E, et al. Cellular and ionic basis of arrhythmias in post infarction remodeled ventricular myocardium. Circ Res 79:461-473, 1996
116. Qin D, Jain P, Boutjdir M, et al. Expression of T-type calcium current in remodeled hypertrophied left ventricle from adult rat following myocardial infarction. Circulation 92(1):I-587, 1995
117. 2+ contents in post infarction myocytes. Am J Physiol 271:C1807, 1996
118. Santos PEB, Barcellos LC, Mill JG, et al. Ventricular action potential and L-type calcium channel in infarct-induced hypertrophy in rats. J Cardiovasc Electrophysiol 6:1004-1014, 1995
119. Pinto JMB, Yuan F, Wasserlauf BJ, et al. Regional gradation of L-Type calcium currents in the feline heart with a healed myocardial infarct. J Cardiovasc Electrophysiol 8:548-560, 1997
120. + antiporter inhibitor on postischemic reperfusion in pig heart. J Cardiovasc Pharmacol 23:72-78, 1994
121. + exchange inhibitor and its effects in cardiac ischemia. Br J Pharmacol 109:562-568, 1993
122. Anderson SE, Murphy E, Steenbergen C, et al. Na-H exchange in myocardium: Effects of hypoxia and acidification on Na and Ca. Am J Physiol 259:C940-C948, 1990
123. Murphy E, Perlman M, London RE, et al. Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res 68:1250-1258, 1991
124. + exchange inhibition reduces hypertrophy and heart failure after myocardial infarction in rats. Am J Physiol (Heart Circ Physiol) 280:H738-H745, 2001
125. + exchanger in short-term atrial electrophysiological remodeling. Circulation 101:1861-1866, 2000
126. 2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 99:641-648, 1999
127. 2+] rat ventricular myocytes following myocardial infarction. J Physiol (Lond) 517:229-245, 1999
128. Li YH, Rozanski GJ. Effects of human recombinant interleukin-1 on electrical properties of guiney pig ventricular cells. Cardiovasc Res 27:525-530, 1993
129. Roden DM, Kupershmidt S. From genes to channels: Normal mechanisms. Cardiovasc Res 42:318-326, 1999
130. Kreher P, Ristori MT, Corman B, et al. Effects of chronic angiotensin inhibition on the relations between ventricular action potential changes and myocardial hypertrophy in rats. J Cardiovasc Pharmacol 25:75-80, 1995
131. Peschar M, Vermooy K, Vangat WYR, et al. Absence of reeverse electrical remodeling during regression of volume overload hypertrophy in canine ventricles. Cardiovasc Res 58:510-517, 2003